Real-time enrollment status for this pancreatic cancer clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 12:22 PM UTC
| NCT Number | NCT05249101 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Pancreatic Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 70 participants |
| Active Locations | 16 sites in the US |
| Sponsor | CG Pharmaceuticals, Inc |
| Last Updated on CT.gov | December 19, 2025 (Dec 19, 2025) |
As of March 2, 2026: Clinical trial NCT05249101 is currently active_not_recruiting participants. This clinical trial study for pancreatic cancer is not currently accepting new participants at 16 locations across the United States. The study is sponsored by CG Pharmaceuticals, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05249101 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05249101 was last updated Dec 19, 2025 (December 19, 2025). HelloStudys verifies this status automatically.